Home › Funds › THOMPSON SIEGEL & WALMSLEY LLC › HSIC
THOMPSON SIEGEL & WALMSLEY LLC position in HSIC
SCHEIN HENRY INC · Health Care
THOMPSON SIEGEL & WALMSLEY LLC reported holding 445,254 shares of HSIC (SCHEIN HENRY INC) in its Q3 2026 13F filing — a position valued at US$37.4M, representing 0.70% of its reported portfolio and ranking #48 among its reported holdings. THOMPSON SIEGEL & WALMSLEY LLC has disclosed HSIC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How THOMPSON SIEGEL & WALMSLEY LLC's HSIC position evolved
THOMPSON SIEGEL & WALMSLEY LLC first disclosed a stake in HSIC in Q2 2024 at 728,285 shares (US$46.7M). The position peaked in Q3 2024 at 1,003,041 shares, worth US$73.1M. Across 10 filings, THOMPSON SIEGEL & WALMSLEY LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 445,254 shares valued at US$37.4M — a reduction of -260,744 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2024 (shares fell 5% over the following quarter), a 40% trim in Q1 2025 (shares rose 7% over the following quarter), a 40% increase in Q3 2025 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 728.28K | $46.68M | New |
| Q3 2024 | 1.00M | $73.12M | Add |
| Q4 2024 | 852.42K | $58.99M | Reduce |
| Q1 2025 | 513.60K | $35.18M | Reduce |
| Q2 2025 | 613.05K | $44.78M | Add |
| Q3 2025 | 856.55K | $56.85M | Add |
| Q4 2025 | 809.41K | $61.17M | Reduce |
| Q1 2026 | 805.28K | $59.35M | Reduce |
| Q2 2026 | 706.00K | $58.97M | Reduce |
| Q3 2026 | 445.25K | $37.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HSIC and 13F data
HSIC (SCHEIN HENRY INC) is a Health Care company. 24 other funds we track also report a position in HSIC — the largest reported positions include Kohlberg Kravis Roberts & Co. L.P. (US$1.31B), Artisan Partners Limited Partnership (US$462.3M), Southpoint Capital Advisors LP (US$275.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HSIC
- Kohlberg Kravis Roberts & Co. L.P. 15.65M sh · $1.31B · Q3 2026
- Artisan Partners Limited Partnership 5.51M sh · $462.30M · Q3 2026
- Southpoint Capital Advisors LP 3.30M sh · $275.62M · Q2 2026
- Palestra Capital Management LLC 2.45M sh · $204.35M · Q2 2026
- LYRICAL ASSET MANAGEMENT LP 1.50M sh · $126.34M · Q3 2026
- M.D. Sass, LLC 1.29M sh · $107.49M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 1.29M sh · $107.34M · Q2 2026
More on THOMPSON SIEGEL & WALMSLEY LLC
FAQ
How long has THOMPSON SIEGEL & WALMSLEY LLC held HSIC?
THOMPSON SIEGEL & WALMSLEY LLC has disclosed HSIC holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is THOMPSON SIEGEL & WALMSLEY LLC's current position in HSIC?
As of Q3 2026, THOMPSON SIEGEL & WALMSLEY LLC holds 445.25K shares of HSIC (SCHEIN HENRY INC), valued at $37.39M, representing 0.70% of its reported portfolio and ranking #48.
Has THOMPSON SIEGEL & WALMSLEY LLC been buying or selling HSIC?
In the latest 13F filing (Q3 2026), THOMPSON SIEGEL & WALMSLEY LLC reduced its position in HSIC. The position peaked in Q3 2024 at 1.00M shares.
Which other funds hold HSIC?
Other major institutional holders of HSIC include Kohlberg Kravis Roberts & Co. L.P., Artisan Partners Limited Partnership, Southpoint Capital Advisors LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.